NCT05652686 A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study) Status RECRUITING Phase PHASE1/PHASE2
NCT05646862 A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05645692 A Study Evaluating Different Immunotherapies (LAG-3 and PD-1 With or Without TIGIT, Compared to PD-L1 Alone) in Participants With Untreated Locally Advanced Metastatic Urothelial Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05642312 A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema Status COMPLETED Phase PHASE3
NCT05634499 A Study of Giredestrant in Participants With Grade 1 Endometrial Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05630066 A Study to Investigate the Pharmacokinetics (PK) and Safety and to Provide Proof of Mechanism of Alogabat in Children and Adolescents Aged 5-17 Years With Angelman Syndrome (AS) With Deletion Genotype. Status COMPLETED Phase PHASE2
NCT05627557 A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05619744 A Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Anti-tumor Activity of RO7616789 in Advanced Small Cell Lung Cancer and Other Neuroendocrine Carcinomas Status COMPLETED Phase PHASE1
NCT05614895 A Study to Investigate the Pharmacokinetics of RO7223280 in Critically Ill Participants With Bacterial Infections Status COMPLETED Phase PHASE1
NCT05610319 Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05595642 A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05593094 A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05583617 A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple Myeloma Status RECRUITING Phase PHASE1/PHASE2
NCT05569148 A Study in Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema to Evaluate the Safety of the Faricimab Prefilled Syringe Status COMPLETED Phase PHASE3
NCT05562947 A Study of the Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System With Ranibizumab (PDS) in Chinese Participants With Neovascular Age-related Macular Degeneration (nAMD) Status RECRUITING Phase PHASE3
NCT05548556 A Study to Evaluate RO7204239 in Participants With Facioscapulohumeral Muscular Dystrophy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05535244 A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed Participants With Relapsed/Refractory Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05533775 A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma Status RECRUITING Phase PHASE1/PHASE2
NCT05503264 A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis Status RECRUITING Phase PHASE3